2e 2 5d 16
19
1b
31

Ali Nabavizadeh, MD

78 faculty photo 77
Associate Professor of Radiology at the Hospital of the University of Pennsylvania
28
6b
Active Radiologist, Penn Presbyterian Medical Center
63
Active Radiologist , Chester County Hospital
61
Active Radiologist , Pennsylvania Hospital
78
Attending Radiologist, Hospital of the University of Pennsylvania
11
3 60
Department: Radiology
4 1 b
1d
46 Contact information
58
Hospital of the University of Pennsylvania
1f Department of Radiology
35 3400 Spruce Street
Philadelphia, PA 19104
26
35
f
4 3 3 1d
18 Publications
23 a
3 2 29 4 b 1f
13 Education:
21 7 MD 1f (School of Medicine) c
2e Shiraz Medical School, 2002.
c
3 3 3 3 8d Permanent link
2 29
 
1d
25
21
b6 > Perelman School of Medicine   > Faculty   > Details a
1e 1d
5e

Description of Clinical Expertise

f3 Dr. Nabavizadeh is primarily an adult neuroradiologist with additional training in pediatric neuroradiology and nuclear radiology. He specializes in using neuroimaging to diagnose various diseases of the central nervous system.
71

Description of Research Expertise

429 Dr. Nabavizadeh is an Associate Professor of Radiology at the Hospital of the University of Pennsylvania with a research appointment at the Children’s Hospital of Philadelphia and the imaging lead of two consortia, CBTN (The Children’s Brain Tumor Network) dedicated to biospecimen-driven data generation. Dr. Nabavizadeh’s research focuses on multimodality imaging using structural and physiologic MRI imaging with additional PET probes and molecular imaging techniques to better understand the complex nature of brain tumor microenvironment. Dr. Nabavizadeh is the associate editor for the brain tumor section at the American Journal of Neuroradiology and has more than 140 peer-reviewed publications in prestigious journals such as Nature Medicine, Nature Communications, JAMA Neurology, Clinical Cancer Research, Neuro-Oncology, Radiology, and Journal of Nuclear Medicine. He has served as the principal investigator of multiple prospective imaging trials including investigator-initiated trials and industry-sponsored FDA registry trials.
e 29
23

Selected Publications

199 Chrysochoou D, Gandhi DB, Adib S, Familiar AM, Vunnava B, Varshochi S, Khalili N, Khalili N, Ware JB, Tu W, Jain P, Anderson H, Haldar S, Storm PB, Franson A, Prados M, Kline C, Mueller S, Resnick A, Vossough A, Davatzikos C, Nabavizadeh A, Kazerooni AF.: AI-powered segmentation and prognosis with missing MRI in pediatric brain tumors. NPJ Precis Oncol 1e Jan 2026.

2c4 Ivanidze J, Vu KV, Fu R, Brandmaier A, Szidonya L, Choudhary G, Starkey J, Wang TJ, Sisti M, McKhann LG, Puri S, Konner M, Roytman M, Lin E, Kuhn A, Osborne JR, Stieg PE, Beal K, Ramakrishna RR, Singh G, Lignelli-Dipple A, Doubrovin M, Vo AH, Welch M, Iwamoto F, Haggiagi A, Donovan L, Diaz M, Gill B, Liechty B, Pisapia DJ, Walker J, Magge RS, Wood M, Corzo VM, Sanusi OR, Raslan A, Dogan A, Bowden S, Nehmeh SA, Nickerson J, Mallak N, Ruiz A, Ambady P, Nabavizadeh A, Barajas RF Jr.: Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma. AJNR Am J Neuroradiol 1e Dec 2025.

132 Nabavizadeh A, Narsinh K, Kaufmann TJ, Liu H, Pouliopoulos AN, Prada F, Agarwal V, Ellingson BM, Sanvito F, Everson RG, Meng Y, Gandhi D, Chang SM, Wen PY, Ahluwalia MS, Sul N, Hadley L, Leblang S, Shah BR, Arvanitis CD, Burns TC, Moosa S, Woodworth GF.: 81 Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical Applications. AJNR Am J Neuroradiol 1e Dec 2025.

16d Jung G, Liang Z, Jain P, Deutsch HM, Li F, Rathi KS, Sun Z, Chen X, Straka J, Kazerooni AF, Sun Y, Koptyra MP, Sanchez-Maldonado S, Familiar A, Waanders AJ, Nabavizadeh A, Huang X, Resnick AC, Song Y.: Role of repulsive guidance signaling and GPR180 in pediatric low-grade glioma infiltration. NPJ Precis Oncol 29 9(1): 344, Nov 2025.

23f Yu B, Kline C, Hoare O, Jung J, Knowles T, Ranavaya A, Minturn J, Banerjee A, Leary S, Crotty E, Abdelbaki M, Whipple N, Goldman S, Margol A, Bhatia A, Dababo N, George E, Nabavizadeh A, Pampaloni MH, Inagaki A, Collins S, Chuntova P, Barcova M, Patel TS, Phillips J, Prados M, Molinaro A, Gupta N, Raffel C, Cole K, Kasahara N, Diaz AA, Mueller S.: Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor: results from PNOC005. Clin Cancer Res 5b 31(16): 3463-3475, Aug 2025 Notes: doi: 10.1158/1078-0432.CCR-24-3721.

2ef Bagley SJ, Desai AS, Fraietta JA, Silverbush D, Chafamo D, Freeburg NF, Gopikrishna GK, Rech AJ, Nabavizadeh A, Bagley LJ, Park J, Jarocha D, Martins R, Sarmiento N, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz RM, Jadlowsky JK, Mackey S, Christensen S, Oner BS, Plesa G, Brennan A, Gonzalez V, Chen F, Barrett D, Colbourn R, Nasrallah MP, Mourelatos Z, Hwang WT, Alanio C, Siegel DL, June CH, Hexner EO, Binder ZA, O'Rourke DM.: Intracerebroventricular bivalent CAR T cells targeting EGFR epitope 806 and IL-13Rα2 in recurrent glioblastoma: a phase 1 dose finding study. Nature Medicine 31(8): 2778-2787, Aug 2025 Notes: doi: 10.1038/s41591-025-03745-0. Epub 2025 Jun 1.

219 Climent Pardo JC, Zapaishchykova A, Boyd A, Tak D, Zielke J, Mahootiha M, Ye Z, Vajapeyam S, Jones J, Smith C, Familiar AM, Nabavizadeh A, Bandopadhayay P, Mueller S, Aerts HJWL, Haas-Kogan DA, Michor F, Ligon KL, Poussaint TY, Faghihroohi S, Kann BH.: Deep learning volumetrics reveal distinct clinical trajectories for pediatric low-grade gliomas under surveillance: A multicenter study. Neurooncol Adv 7(1): vdaf145, Jul 2025 Notes: doi: 10.1093/noajnl/vdaf145.

15c Familiar AM, Khalili N, Khalili N, Schuman C, Grove E, Viswanathan K, Seidlitz J, Alexander-Bloch A, Zapaishchykova A, Kann BH, Vossough A, Storm PB, Resnick AC, Kazerooni AF, Nabavizadeh A.: Empowering Data Sharing in Neuroscience: A Deep Learning Deidentification Method for Pediatric Brain MRIs 67 AJNR Am J Neuroradiol 46(5): 964-972, May 2025 Notes: doi: 10.3174/ajnr.A8581.

124 Divyanshu Tak , Biniam A. Garomsa , Anna Zapaishchykova , Zezhong Ye , Sridhar Vajapeyam , Maryam Mahootiha , Juan Carlos Climent Pardo ,Ceilidh Smith , Ariana M. Familiar , Tafadzwa Chaunzwa , Kevin X. Liu , Sanjay Prabhu , Pratiti Bandopadhayay , f9 Ali Nabavizadeh , Sabine Mueller , Hugo J. W. L. Aerts , Daphne Haas-Kogan , Tina Y. Poussaint , Benjamin H. Kann.: Longitudinal Risk Prediction for Pediatric Glioma with Temporal Deep Learning. NEJM AI 2(5), May 2025.

21a Till JE, Seewald NJ, Yazdani Z, Wang Z, Ballinger D, Samberg H, Dandu S, Macia C, Yin M, Abdalla A, Prior T, Shah S, Patel T, McCoy E, Mansour M, Wills CA, Bochenek V, Serrano J, Snuderl M, Phillips RE, O'Rourke DM, Amankulor NM, Nabavizadeh A, Desai AS, Gollomp K, Binder ZA, Zhou W, Bagley SJ, Carpenter EL.: Corticosteroid-dependent association between prognostic peripheral blood cell-free DNA levels and neutrophil-mediated NETosis in patients with glioblastoma. Clin Cancer Res 5a 31(7): 1292-1304, Apr 2025 Notes: doi: 10.1158/1078-0432.CCR-24-3169.

2c
7 1d
2c back to top
26 Last updated: 01/15/2026
34 The Trustees of the University of Pennsylvania c
1f
27
24
 
1d
18
1 49 2 2 18